评估重新抽样方法的性能,以内部验证依赖于时间的二元指标与时间到事件结果之间的关联。

IF 1.2 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Caroline A Falvey, Jamie L Todd, Megan L Neely
{"title":"评估重新抽样方法的性能,以内部验证依赖于时间的二元指标与时间到事件结果之间的关联。","authors":"Caroline A Falvey, Jamie L Todd, Megan L Neely","doi":"10.1080/10543406.2025.2489293","DOIUrl":null,"url":null,"abstract":"<p><p>Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understanding the association between a risk factor ever occurring in follow-up and the future risk of an outcome. If such an association is found, researchers are often asked to validate the finding. External validation is often infeasible, and validation may only be performed internally. However, the performance of internal validation methods in the setting of a time-dependent binary indicator and a time-to-event outcome has not been well-studied. We emulated a dataset motivated by real-world serial biomarker observations and performed extensive simulation studies to evaluate the performance of a resampling-based method to internally validate the association between a time-dependent binary indicator and a time-to-event outcome. We found the resampling-based method achieved optimal power for validating such an association while maintaining good Type I error control.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1-11"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating the performance of a resampling approach for internally validating the association between a time-dependent binary indicator and time-to-event outcome.\",\"authors\":\"Caroline A Falvey, Jamie L Todd, Megan L Neely\",\"doi\":\"10.1080/10543406.2025.2489293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understanding the association between a risk factor ever occurring in follow-up and the future risk of an outcome. If such an association is found, researchers are often asked to validate the finding. External validation is often infeasible, and validation may only be performed internally. However, the performance of internal validation methods in the setting of a time-dependent binary indicator and a time-to-event outcome has not been well-studied. We emulated a dataset motivated by real-world serial biomarker observations and performed extensive simulation studies to evaluate the performance of a resampling-based method to internally validate the association between a time-dependent binary indicator and a time-to-event outcome. We found the resampling-based method achieved optimal power for validating such an association while maintaining good Type I error control.</p>\",\"PeriodicalId\":54870,\"journal\":{\"name\":\"Journal of Biopharmaceutical Statistics\",\"volume\":\" \",\"pages\":\"1-11\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biopharmaceutical Statistics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10543406.2025.2489293\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biopharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10543406.2025.2489293","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

确定疾病的临床或生物学风险因素在实现早期疾病诊断、预后结果评估以及可能为疾病预防或监测实践提供信息方面发挥关键作用。通常检查的一个框架是了解随访中曾经发生的风险因素与结果的未来风险之间的关系。如果发现了这种联系,研究人员通常会被要求验证这一发现。外部验证通常是不可行的,并且验证可能只能在内部执行。然而,内部验证方法的性能在一个时间相关的二进制指标和时间到事件的结果的设置还没有得到很好的研究。我们模拟了一个由真实世界的一系列生物标志物观察激发的数据集,并进行了广泛的模拟研究,以评估基于重采样的方法的性能,以内部验证依赖时间的二进制指标与时间到事件结果之间的关联。我们发现基于重采样的方法在保持良好的I型误差控制的同时达到了验证这种关联的最佳功率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluating the performance of a resampling approach for internally validating the association between a time-dependent binary indicator and time-to-event outcome.

Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understanding the association between a risk factor ever occurring in follow-up and the future risk of an outcome. If such an association is found, researchers are often asked to validate the finding. External validation is often infeasible, and validation may only be performed internally. However, the performance of internal validation methods in the setting of a time-dependent binary indicator and a time-to-event outcome has not been well-studied. We emulated a dataset motivated by real-world serial biomarker observations and performed extensive simulation studies to evaluate the performance of a resampling-based method to internally validate the association between a time-dependent binary indicator and a time-to-event outcome. We found the resampling-based method achieved optimal power for validating such an association while maintaining good Type I error control.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Biopharmaceutical Statistics
Journal of Biopharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.50
自引率
18.20%
发文量
71
审稿时长
6-12 weeks
期刊介绍: The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信